Recurrent Ovarian Cancer Online

Progression-free Survival

A tool for researcher and health care professionals to prognosticate progression-free survival decisions in patients with recurrent ovarian cancer treated with platinum-based chemotherapy.

Note that our website is currently experiencing compatibility issues with Windows 8 operating system and also with Internet Explorer 10. If you are using both or either of these, please click here for instructions on how to enable the compatibility view settings to overcome these issues. Alternatively, if available please use Internet Explorer 7, 8, or 9.

Your Patient Characteristics at Disease Relapse

Largest Tumour size
Last platinum chemotherapy (months)
CA-125 (IU/mL)
Number of organ sites of metastasis
White blood cell (x 109/L)